Literature DB >> 10816655

alpha-MSH and the regulation of melanocyte function.

A J Thody1.   

Abstract

alpha-MSH, has numerous actions in the skin and by activating the MC1 receptor (MC1-R) on melanocytes it stimulates melanogenesis. Rather than producing large increase in melanin production alpha-MSH acts specifically to stimulate eumelanin synthesis. Although this could be important in determining skin color and tanning there is debate as to the pigmentary significance of alpha-MSH in humans. Circulating levels of alpha-MSH are negligible and although it is produced in the skin by different cell types, including melanocytes, the major skin form is desacetyl alpha-MSH, and this is a weak agonist at MC1-R. Certain ACTH peptides, notably ACTH1-17, are more potent agonists at the MC1-R and, since their skin concentrations exceed those of alpha-MSH, they could serve as natural ligands at this receptor and regulate pigmentary responses in humans. Activation of MC1-R does, however, produce other responses in human melanocytes. Thus, alpha-MSH stimulates melanocyte dendricity and attachment to extracellular matrix proteins. It also protects melanocytes from the damaging effects of oxidative stress, and regulates their production of NO by modulating the induction of iNOS--as it does within macrophages. alpha-MSH clearly affects various aspects of melanocyte behavior and its melanogenic effects could be the consequence of a more fundamental role in the melanocyte. The precise nature of this role is unclear, but it could be part of a generic role that alpha-MSH and other POMC peptides have in skin homeostasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10816655     DOI: 10.1111/j.1749-6632.1999.tb08679.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

Review 1.  Hypopigmentary skin disorders: current treatment options and future directions.

Authors:  Anke Hartmann; Eva-B Bröcker; Jürgen C Becker
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Neonatal melanocortin receptor agonist treatment reduces play fighting and promotes adult attachment in prairie voles in a sex-dependent manner.

Authors:  Catherine E Barrett; Meera E Modi; Billy C Zhang; Hasse Walum; Kiyoshi Inoue; Larry J Young
Journal:  Neuropharmacology       Date:  2014-06-09       Impact factor: 5.250

3.  Gene transfer to chicks using lentiviral vectors administered via the embryonic chorioallantoic membrane.

Authors:  Gideon Hen; Sara Yosefi; Dmitry Shinder; Adi Or; Sivan Mygdal; Reba Condiotti; Eithan Galun; Amir Bor; Dalit Sela-Donenfeld; Miriam Friedman-Einat
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

Review 4.  Vitiligo, From Physiopathology to Emerging Treatments: A Review.

Authors:  Laure Migayron; Katia Boniface; Julien Seneschal
Journal:  Dermatol Ther (Heidelb)       Date:  2020-09-19

5.  Identification of the ceRNA networks in α-MSH-induced melanogenesis of melanocytes.

Authors:  Ling Jiang; Jinhua Huang; Yibo Hu; Li Lei; Yujie Ouyang; Yan Long; Hui Li; Si Li; Lun Yang; Yan Yang; Lihua Huang; Hong Xiang; Rong Xiao; Jing Chen; Qinghai Zeng
Journal:  Aging (Albany NY)       Date:  2020-12-14       Impact factor: 5.682

6.  Melanocytes derived from transgene-free human induced pluripotent stem cells.

Authors:  Jennifer C Jones; Karen Sabatini; Xiaoyan Liao; Ha T Tran; Candace L Lynch; Robert E Morey; Victoria Glenn-Pratola; Francesca S Boscolo; Qinghong Yang; Mana M Parast; Ying Liu; Suzanne E Peterson; Louise C Laurent; Jeanne F Loring; Yu-Chieh Wang
Journal:  J Invest Dermatol       Date:  2013-03-20       Impact factor: 8.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.